Evidence map›Paper›PMID 36589010›Full record

ArticleHeart rhythm O22022

Feasibility and safety of a transvenous lead extraction program implementation in South America: Challenges, early outcomes, and global collaboration-A single-center experience.

Pablo Salazar, Armando Pérez-Silva, Alex Villablanca, Francisco Bello, Osvaldo Pérez, Andrew Beaser, Hemal Nayak

Abstract read
In one paragraph

Article in Heart rhythm O2, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pablo SalazarDepartment of Cardiology, Electrophysiology Division, Hospital las Higuera's, Talcahuano, Chile.
Armando Pérez-SilvaDepartment of Cardiology, Electrophysiology Division, Hospital las Higuera's, Talcahuano, Chile.
Alex VillablancaDepartment of Cardiology, Electrophysiology Division, Hospital las Higuera's, Talcahuano, Chile.
Francisco BelloDepartment of Cardiology, Electrophysiology Division, Hospital las Higuera's, Talcahuano, Chile.
Osvaldo PérezDepartment of Cardiology, Electrophysiology Division, Hospital las Higuera's, Talcahuano, Chile.
Andrew BeaserDepartment of Cardiology, Center for Arrhythmia Care, The University of Chicago, Pritzker School of Medicine, Chicago, Illinois.
Hemal NayakDepartment of Cardiology, Center for Arrhythmia Care, The University of Chicago, Pritzker School of Medicine, Chicago, Illinois.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Transvenous lead extraction is the standard of care for cardiac implantable electronic device (CIED) malfunction/infection-related removal. However, data on its performance and results in underdeveloped countries are limited. Objective: The purpose of this study was to report the feasibility and efficacy of a lead extraction program in a tertiary hospital in Chile, South America. Methods: Patients requiring CIED removal at the Electrophysiology Division of the Hospital las Higuera's were retrospectively analyzed. Outcomes including procedure-related mortality, procedural success and failure, and cardiac and vascular complications were reported. Results: A total of 15 patients were analyzed (median age 68 [interquartile range 52-75] years; 80% male). Patients with lead extraction difficulty index >10 represented 33% of patients. Infection was the indication for removal in all patients, with pocket infection (80%). Mechanical rotational tools were used in 66% of cases, and a total of 29 leads were removed. Procedural success was accomplished in 93% of cases. There was 1 (7%) intraprocedural complication and no procedure-related mortality. Conclusions: The development of a lead management program is feasible, safe, and effective in underdeveloped countries.

Indexed as

ElectrophysiologyLead complicationsLead extractionLead managementSouth America

Identifiers

PMID36589010
PMCPMC9795241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.